All
Leadership Changes at Solving Kids’ Cancer
FOR IMMEDIATE RELEASE January 7, 2025 Exciting New Leadership and Growth for Solving Kids’ Cancer in 2025 New York, NY – Solving Kids’ Cancer (SKC) is pleased to announce significant organizational updates as it embarks on an exciting new chapter in 2025. With growth across its Board of Directors and executive leadership, the organization is…
Ways to Give Back During the Holidays
Holiday Fundraiser Ideas to Support Kids with Cancer For most, the holidays mean joy, togetherness, and warm memories by the fire. But for families facing pediatric cancer, this season can feel anything but magical. A cancer diagnosis doesn’t pause for the holidays. Families balance treatment plans, hospital visits, and everyday life while holiday traditions take…
Ahana’s Story of Strength
Ahana’s Story of Strength with High-Risk Neuroblastoma Every day, over 1,000 children worldwide are diagnosed with cancer,1 and for many families, that diagnosis means facing an uncertain future. At just 20 months old, Ahana was diagnosed with a rare and aggressive cancer that had already spread through her small body. Her family’s search for life-saving childhood…
2024 Year-in-Review
Advancing Childhood Cancer Research: SKC’s 2024 Milestones Dear Friends and Supporters, As we look back on 2024, I want to extend my heartfelt thanks to every donor, volunteer, and partner who has stood with us. Because of you, Solving Kids’ Cancer has been able to push forward with groundbreaking research and open new doors to…
2024 Lace Up for Kids Recap
Lace Up for Kids: Your Impact on Childhood Cancer Research At Solving Kids’ Cancer, our mission has always been driven by hope — hope for better treatments, hope for breakthroughs, and most importantly, hope for every child fighting cancer. This year’s Lace Up for Kids campaign was nothing short of inspiring. Together, we’ve raised over…
Lace Up for Kids: Stories of Impact: Erin Martin
Gold Laces for Childhood Cancer Awareness Month: Erin’s Story Erin Martin’s journey began with a simple pair of gold shoelaces, but it has grown into a powerful mission to make a difference in the fight against childhood cancer. At just 14 years old, Erin has dedicated herself to raising awareness and funds for pediatric cancer…
Smithtown Goes Gold for Childhood Cancer
Smithtown Goes Gold for Childhood Cancer Awareness Month! In Smithtown, New York, gold shoelaces are more than just a fashion statement — they’re a symbol of hope and unity. Every September, the town transforms into a vibrant celebration of community spirit and determination to fight childhood cancer. September is Childhood Cancer Awareness Month and Pediatric…
Osteosarcoma Survivor Dr. Kurt Weiss
Osteosarcoma Survivor to Surgeon: Dr. Kurt Weiss’ Story At age 15, Dr. Kurt Weiss was a typical teenager—active, ambitious, and full of dreams about football, college, and mountain climbing. However, during a football practice, a sudden, severe pain in his leg changed everything. His mother insisted he visit the doctor, even suggesting she might cancel…
National Cancer Survivors Month
Jacob’s Journey: A Childhood Cancer Survivor’s Story Every battle has its heroes, and among the bravest are young children like Jacob Mozer, who faced stage 4 high-risk neuroblastoma when he was barely old enough to walk. Diagnosed at only 16 months old, Jacob’s early years were filled with constant medical appointments and intense treatments. Despite…
Podcast & Webinars
This Week in Pediatric Oncology (TWiPO): A Podcast Dedicated to Sharing Ideas & Working Together for Cures
Childhood cancer is a complicated disease. Whether you’re a clinician, researcher yourself or caring for a child with cancer, we want to give you the tools to deepen your understanding. For more than a decade, Solving Kids’ Cancer has earned a seat at the table among some of the most inspiring researchers and like-minded organizations…
Press Release
Leadership Changes at Solving Kids’ Cancer
FOR IMMEDIATE RELEASE January 7, 2025 Exciting New Leadership and Growth for Solving Kids’ Cancer in 2025 New York, NY – Solving Kids’ Cancer (SKC) is pleased to announce significant organizational updates as it embarks on an exciting new chapter in 2025. With growth across its Board of Directors and executive leadership, the organization is…
Collaborative Effort of Nonprofits Yields Big Results for Treating High-Risk Neuroblastoma
FOR IMMEDIATE RELEASE Collaborative Effort of Nonprofits Yields Big Results for Treating High-Risk Neuroblastoma New York, NY, April 3, 2023 —The collaborative efforts of eight nonprofit organizations to impact survival rates of children with high-risk neuroblastoma by funding innovative clinical research has just resulted in very promising results. This collaboration, led by…
Clinical Trial Harnesses Power of Natural Killer Cells to Treat Neuroblastoma
Solving Kids’ Cancer, The Catherine Elizabeth Blair Memorial Foundation, and Wade’s Army awarded a $136,000 grant to support the novel immunotherapy clinical trial for childhood cancer. Researchers will use a humanized monoclonal antibody linked to IL2, known as hu14.18-IL2, which specifically targets neuroblastoma tumor cells and binds to them, while the IL2 activates NK cells…
Targeted Therapy for Children with ALK-Driven Neuroblastoma
Lorlatinib, an investigational drug candidate currently in late-stage clinical development for the treatment of lung cancer may also prove effective for the treatment of the pediatric cancer neuroblastoma. Solving Kids’ Cancer is leading an international effort of like-minded nonprofits to provide nearly $400,000 of collaborative funding for an innovative clinical trial to bring a potentially life-saving therapy to kids.
Advocacy in Action
Solving Kids’ Cancer was the first charity to ever go against the UK healthcare system without a pharmaceutical company involved. As a result, the National Institute for Health and Care Excellence (NICE) recently announced that it has upheld SKC’s appeal against the Institute’s decision not to recommend dinutuximab for treating high-risk neuroblastoma.
Precision Medicine Advances for Children With Neuroblastoma
Solving Kids’ Cancer (SKC) together with Wade’s Army announce their joint financial support of this Phase 1 clinical trial to test the safety and efficacy of various investigational drugs that will leverage precision medicine for children with neuroblastoma. This Next Generation Personalized Neuroblastoma Therapy – also known as NEPENTHE (Greek for “medicine for sorrow”) – is the first precision medicine trial for children that will robustly analyze the genomics of their cancer and use combinations of investigational drugs to target specific mutations in their tumors.
Children with High Grade Brain Tumors will be able to Receive Cutting-edge Oncolytic Virus Therapy
The Andrew McDonough B+ Foundation (The B+ Foundation) and Solving Kids’ Cancer (SKC) presented a check for $208,500 to Dr. Matthias Gromeier and Dr. Eric Thompson at the Preston Robert Tisch Brain Tumor Center at Duke, to co-fund an exciting new immunotherapy trial for children with deadly brain tumors.
The Launch of an International Immunotherapy Trial for Children with Brain Tumors
A Kids’ Brain Tumor Cure Foundation, Solving Kids’ Cancer, and the Ty Louis Campbell (TLC) Foundation announce their joint financial support of a Phase 1 clinical trial to test the safety and efficacy of combination checkpoint inhibitors in the treatment of children with brain tumors.
SKC Formally Appeals NICE Decision
The National Institute for Health and Care Excellence (NICE) heard an appeal led by Solving Kids’ Cancer (SKC) against its recent decision to deny children in the UK treatment that is proven to significantly increase the chance of survival for children diagnosed with an aggressive childhood cancer, neuroblastoma.
News & Views
Ways to Give Back During the Holidays
Holiday Fundraiser Ideas to Support Kids with Cancer For most, the holidays mean joy, togetherness, and warm memories by the fire. But for families facing pediatric cancer, this season can feel anything but magical. A cancer diagnosis doesn’t pause for the holidays. Families balance treatment plans, hospital visits, and everyday life while holiday traditions take…
Ahana’s Story of Strength
Ahana’s Story of Strength with High-Risk Neuroblastoma Every day, over 1,000 children worldwide are diagnosed with cancer,1 and for many families, that diagnosis means facing an uncertain future. At just 20 months old, Ahana was diagnosed with a rare and aggressive cancer that had already spread through her small body. Her family’s search for life-saving childhood…
2024 Year-in-Review
Advancing Childhood Cancer Research: SKC’s 2024 Milestones Dear Friends and Supporters, As we look back on 2024, I want to extend my heartfelt thanks to every donor, volunteer, and partner who has stood with us. Because of you, Solving Kids’ Cancer has been able to push forward with groundbreaking research and open new doors to…
2024 Lace Up for Kids Recap
Lace Up for Kids: Your Impact on Childhood Cancer Research At Solving Kids’ Cancer, our mission has always been driven by hope — hope for better treatments, hope for breakthroughs, and most importantly, hope for every child fighting cancer. This year’s Lace Up for Kids campaign was nothing short of inspiring. Together, we’ve raised over…
Lace Up for Kids: Stories of Impact: Erin Martin
Gold Laces for Childhood Cancer Awareness Month: Erin’s Story Erin Martin’s journey began with a simple pair of gold shoelaces, but it has grown into a powerful mission to make a difference in the fight against childhood cancer. At just 14 years old, Erin has dedicated herself to raising awareness and funds for pediatric cancer…
Smithtown Goes Gold for Childhood Cancer
Smithtown Goes Gold for Childhood Cancer Awareness Month! In Smithtown, New York, gold shoelaces are more than just a fashion statement — they’re a symbol of hope and unity. Every September, the town transforms into a vibrant celebration of community spirit and determination to fight childhood cancer. September is Childhood Cancer Awareness Month and Pediatric…
Osteosarcoma Survivor Dr. Kurt Weiss
Osteosarcoma Survivor to Surgeon: Dr. Kurt Weiss’ Story At age 15, Dr. Kurt Weiss was a typical teenager—active, ambitious, and full of dreams about football, college, and mountain climbing. However, during a football practice, a sudden, severe pain in his leg changed everything. His mother insisted he visit the doctor, even suggesting she might cancel…
National Cancer Survivors Month
Jacob’s Journey: A Childhood Cancer Survivor’s Story Every battle has its heroes, and among the bravest are young children like Jacob Mozer, who faced stage 4 high-risk neuroblastoma when he was barely old enough to walk. Diagnosed at only 16 months old, Jacob’s early years were filled with constant medical appointments and intense treatments. Despite…
Trailblazing Treatments for Pediatric Brain Tumors
Trailblazing Treatments for Pediatric Brain Tumors Picture a fortress built to guard precious treasure but accidentally also keeps out the very allies it needs in a time of crisis. This is the challenge faced by medical researchers when dealing with the brain’s natural defense — the blood-brain barrier — especially in children with brain tumors. …
Videos
Accelerating Research For Pediatric Brain Tumors
Meet Dr. Mark Souweidane from Weill Cornell Medical Center and listen in as we interview him and two childhood cancer families about his clinical trial that Solving Kids’ Cancer funded for children with brain tumors.
Understanding the Landscape, Strengthening the Science, Curing and Caring for the Child
Solving Kids’ Cancer’s approach is to understand the research landscape, strengthen the science, cure, and care for the child. The GD2 T Cell Therapy trial at Texas Children’s Hospital is helping children with neuroblastoma like Kyra Kardong – listen to her story.
The Promise of Immunotherapy
Immunotherapy is changing the paradigm for children with cancer. Solving Kids’ Cancer has teamed up with the same researchers who helped save Emily Whitehead’s life to bring a new treatment option for children with neuroblastoma. Meet one family that was on a Solving Kids’ Cancer clinical trial at the Children’s Hospital of Philadelphia
Solving Kids’ Cancer Nifurtimox trial: Meet one Family
Jordyn being diagnosed at 6 months old with neuroblastoma was a devastating shock for her mother, Jodie. After 6 ineffective rounds of chemotherapy, radiation, and surgery Jodie was left without any options, which in turn lead her to an experimental clinical trial sponsored by Solving Kids’ Cancer. This is the story of their journey to save Jordyn.
Searching for a Solution: An SKC Feature
Al Jazeera America covered the story of Solving Kids’ Cancer’s co-founders, Scott Kennedy & John London, and why they created the organization. Listen in on their stories and the inspiration behind the making of Solving Kids’ Cancer.
Challenging the Status Quo
“Solving Kids’ Cancer and the TDI offer the opportunity to develop a much more facile system for drug development.” – Dr. Kenneth Cohen from the Sidney Kimmel Cancer Center at John Hopkins University